Salih Çağrı ÇAKIR, Bayram Ali DORUM, Hilal ÖZKAN, Özgür TAŞKAPILIOĞLU, Nilgün KÖKSAL, Rabia TÜTÜNCÜ TOKER, Mehmet Sait OKAN

Nöral Tüp Defektli Yenidoğanların Kısa Dönem Sonuçları Short-Term Clinical Outcomes of Newborns Who Have Neural Tube Defects

GİRİŞ ve AMAÇ: Nöral tüp defektleri (NTD) yenidoğanlarda en sık saptanan konjenital anomalilerden biridir. Türkiyedeki görülme sıklığı 3/1000’dir. NTD’lerin etiyolojisi multifaktöriyel olup önemli bir kısmının folik asit desteği ile önlenebilmesi mümkündür. NTD olan hastaların uzun dönem medikal, cerrahi ve bakım desteği ihtiyacı vardır.

Anahtar Kelimeler:

Nöral tüp defektleri, meningosel, meningomiyolesel, yenidoğan

Short-Term Clinical Outcomes of Newborns Who Have Neural Tube Defects

PDF

___

1. Greene NDE, Copp AJ. Neural Tube Defects. Annu Rev Neurosci. 2014;37:221–42.
2. Murat A, Aras M, Altaş ZG, Aras Z, Seraslan Y, Yılmaz N. Nöral Tüp Defektli Hastalara Retrospektif Bakış. Mustafa Kemal Üniversitesi Tıp Derg. 2012;3(9):22–8.
3. Tunçbilek E. Türkiye’deki yüksek nöral tüp defekti sıklığı ve önlemek için yapılabilecekler. Çocuk Sağlığı ve Hast Derg. 2004;47:79–84.
4. American College of Obstetricians and Gynecologists. Neural tube defects. Practice Bulletin No. 187. Obstet Gynecol. 2017;130(6):e279–90.
5. Castillo-Lancellotti C, Tur JA, Uauy R. Impact of folic acid fortification of flour on neural tube defects: A systematic review. Public Health Nutr. 2013;16(5):901–11.
6. Prakash, Prabhu L V., Nasar MA, Rai R, Madhyastha S, Singh G. Lamotrigine in pregnancy: Safety profile and the risk of malformations. Singapore Med J. 2007;48(10):880–3.
7. Karaca NE, Karaca E, Onay H, Gunduz C, Egemen A, Ozkinay F. Evaluation of mothers’ MTHFR genotype and other risk factors of neural tube defects in their children. Ege J Med.2012;51(1):37–42.
8. Meng X, Sun Y, Duan W, Jia C. Meta-analysis of the association of maternal smoking and passive smoking during pregnancy with neural tube defects. Int J Gynaecol Obs [Internet]. 2018;140:18–25. Available from: http://doi.wiley.com/10.1002/ijgo.12334
9. Toriello H V, Higgins J V, Opitz JM. Occurrence of neural tube defects among first-, second and third-degree relatives of probands: results of a United States study. Am J Med Genet [Internet]. 1983 Aug [cited 2018 Feb 7];15(4):601–6.
10. Wilson RD, Audibert F, Brock JA, Carroll J, Cartier L, Gagnon A, et al. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies. J Obstet Gynaecol Canada. 2015;37(6):534–49.
11. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LYC. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA [Internet]. 2001 Jun 20 [cited 2018 Feb 7];285(23):2981–6.
12. American College of Obstetricians and Gynecologists. Ultrasound in pregnancy. Practice Bulletin No. 175. Obstet Gynecol. 2016;128(6):1459–60.
13. Sibinski M, Synder M, Higgs ZCJ, Kujawa J, Grzegorzewski A. Quality of life and functional disability in skeletally mature patients with myelomeningocele-related spinal deformity. JPediatr Orthop Part B. 2013;22(2):106–9.
14. Bowman RM, McLone DG, Grant JA, Tomita T, Ito J. Spina Bifida Outcome: A 25-year Prospective. Pediatr Neurosurg. 2001;34(3):114–20.
15. Meuli M, Meuli-Simmen C, Hutchins GM, Seller MJ, Harrison MR, Adzick NS. The spinal cord lesion in human fetuses with myelomeningocele: Implications for fetal surgery. J Pediatr Surg. 1997;32(3):448–52.